New Results
The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China
View ORCID ProfileRohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, View ORCID ProfileHarlan M. Krumholz
doi: https://doi.org/10.1101/218859
Rohan Khera
1Division of Cardiology, UT Southwestern Medical Center, Dallas, Texas
Yuan Lu
2Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, Connecticut
Anshul Saxena
3Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Coral Gables, Florida
Khurram Nasir
3Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Coral Gables, Florida
Harlan M. Krumholz
2Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, Connecticut
4Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine and the Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

Article usage
Posted November 13, 2017.
The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China
Rohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, Harlan M. Krumholz
bioRxiv 218859; doi: https://doi.org/10.1101/218859
Subject Area
Subject Areas
- Biochemistry (9624)
- Bioengineering (7119)
- Bioinformatics (24935)
- Biophysics (12664)
- Cancer Biology (9989)
- Cell Biology (14395)
- Clinical Trials (138)
- Developmental Biology (7986)
- Ecology (12145)
- Epidemiology (2067)
- Evolutionary Biology (16022)
- Genetics (10948)
- Genomics (14776)
- Immunology (9899)
- Microbiology (23732)
- Molecular Biology (9502)
- Neuroscience (51041)
- Paleontology (370)
- Pathology (1544)
- Pharmacology and Toxicology (2692)
- Physiology (4037)
- Plant Biology (8692)
- Synthetic Biology (2404)
- Systems Biology (6455)
- Zoology (1349)